Inventor · disambiguated record
Christian P. Larsen
Also filed as: LARSEN CHRISTIAN P · LARSEN CHRISTIAN PAUL
7 granted patents·10 pending applications·328 citations·filing 1997–2022
88Inventor score
Files withBRISTOL MYERS SQUIBB CO7BETH ISRAEL DEACONESS MEDICAL CT INC3UNIV EMORY2AHMED RAFI1DIGITAL GUARDIAN LLC1
Top patents by PatentIndex Score
17 records- 0197US5916560AMethods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 29, 1999·175 cites·24 claims
- 0295US7304033B2Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 4, 2007·90 cites·32 claims
- 0390US11388183B2Systems and methods for tracking risk on data maintained in computer networked environmentsDIGITAL GUARDIAN LLC·Filed 2019·Granted Jul 12, 2022·32 cites·20 claims
- 0490US7829534B2Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 9, 2010·16 cites·14 claims
- 0588US10561728B2Polynucleotides encoding anti-CD40 antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Feb 18, 2020·4 cites·17 claims
- 0685US9987356B2Anti-CD40 antibodies and methods of administering thereofREIMANN KEITH A·Filed 2012·Granted Jun 5, 2018·9 cites·34 claims
- 0780US8840899B2Use of mTOR inhibitors to enhance T cell immune responsesAHMED RAFI·Filed 2009·Granted Sep 23, 2014·2 cites·13 claims
- 0872US2020261574A1Anti-cd40 antibodies and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 0972US2022133887A1Anti-cd40 antibodies and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2022·Application pending·0 cites
- 1067US2009186037A1Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1163US2014370059A1USE OF mTOR INHIBITORS TO ENHANCE T CELL IMMUNE RESPONSESUNIV EMORY·Filed 2014·Application pending·0 cites
- 1259US2016324834A1Use of mTOR Inhibitors to Enhance T Cell Immune ResponsesUNIV EMORY·Filed 2016·Application pending·0 cites
- 1357US2002031510A1Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 2001·Application pending·0 cites
- 1457US2020231676A1Methods of treating transplant rejection using a domain antibody directed against cd40lBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1556US2005202011A1Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithFiled 2005·Application pending·0 cites
- 1649US2017051059A1Methods of treating transplant rejection using a domain antibody directed against cd40BRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1738US2003007968A1Methods of inducing organ transplant tolerance and correcting hemoglobinopathiesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian P. Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →